Funding Secured: ArrowBiome, Autify, and DataMesh, along with a AUD 300 million agreement between Temasek and Betashares, highlighted by nine Chinese deal closures and additional finance arrangements.
In the bustling landscape of technology and biotechnology, several companies in the Asia-Pacific region have recently secured significant funding to fuel their growth and innovation. Here's a snapshot of some of the recent funding rounds that have taken place.
Biotechnology Breakthroughs
ArrowBiome, a Singapore-based biotechnology company, has received USD 1 million in seed funding from Cocoon Capital. ArrowBiome's technology has demonstrated significant efficacy and selectivity across multiple bacterial strains, with the initial target market for its solutions being the treatment of acne and body odor. The company precisely targets specific bacterial strains using lysins, proteins evolved by bacteriophages.
Battery Innovations
Grinergy, a South Korean startup specializing in lithium-titanate (LTO) batteries, has announced an investment agreement with a global investment group based in North America. LG Energy Solution has also become a financial partner of Grinergy, aiming to support the development and commercialization of ArrowBiome's microbiome management solutions. Grinergy plans to use the funds to expand production facilities and equipment at its Yeoju plant and secure IP for future growth.
Cancer Immunotherapy Advancements
Leman Biotech, a Shenzhen-headquartered clinical-stage biotechnology company focused on cancer immunotherapy, has completed two extended angel funding rounds, securing a total of RMB 50 million (USD 6.8 million).
Artificial Intelligence and Quality Engineering
Autify, an artificial intelligence-driven quality engineering platform, has raised USD 13 million in a Series B funding round. The funding will be used to expand into the South Korean market and strengthen its collaboration with LG CNS.
Gene Therapy Drug Discovery
Innostellar Biotherapeutics, a biopharmaceutical company specializing in gene therapy drug discovery, has completed its Series B+ financing round. The funds raised will accelerate the R&D efforts and market expansion of its platform.
Climate Tech Startup Success
Asuene, a Japan-headquartered climate tech startup, raised USD 26.7 million in the first close of its Series C funding round.
AI Solution Development
SenseArray, an AI solution developer, has raised RMB 50 million in a Series A financing round.
Knowledge-Sharing Platform Expansion
Arches, a knowledge-sharing platform focused on the Asia Pacific region, raised USD 3 million in a funding round led by Kusabi.
Space Tech Company Funding
Huantian Wisdom, a Chengdu-based space tech company, has completed its Series B funding round, with CDH Investments as the lead investor.
Industrial Metaverse Solutions
DataMesh, a Singapore-based provider of digital twin and extended reality (XR) solutions, has closed a new funding round. The funds raised will accelerate the R&D efforts and market expansion of its "industrial metaverse" platform.
B2B Fintech Company Funding
Paper.id, an Indonesian B2B fintech company, raised an undisclosed sum of Series B funding in a round led by Square Peg Capital.
Advanced Driver Assistance Solutions
QCraft, a provider of advanced driver assistance solutions, has raised a nine-figure RMB sum in its Series C financing round from ZGC Science City and Cuihu Fund.
Medtech Company Funding
Leadbio Tech, a Hangzhou-based medtech company, has raised tens of millions of RMB in a Series A+ funding round.
Optoelectronics Chip Supplier Funding
Aluksen Technology, a chip supplier specializing in optoelectronics, has raised an undisclosed amount in its Series B financing round.
Global Investment in Asia-Pacific
Temasek, a global investment firm headquartered in Singapore, has agreed to invest up to AUD 300 million (USD 198.7 million) in Australian ETF manager Betashares.
UK-Korea Collaboration
Grinergy is working with UK-based Snapfast to establish a joint venture for local LTO battery production, supported by UK Research and Innovation (UKRI) funding.
This funding influx signifies a promising future for these innovative companies, as they continue to push the boundaries of technology and biotechnology, contributing to a more sustainable and technologically advanced world.
Read also:
- Understanding Hemorrhagic Gastroenteritis: Key Facts
- Stopping Osteoporosis Treatment: Timeline Considerations
- Expanded Community Health Involvement by CK Birla Hospitals, Jaipur, Maintained Through Consistent Outreach Programs Across Rajasthan
- Abdominal Fat Accumulation: Causes and Strategies for Reduction
